← Back to Search

Nudge for Pre-eclampsia (REMIND Trial)

N/A

Waitlist Available

Led By Jourdan E Triebwasser, MD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months postpartum

Awards & highlights

REMIND Trial Summary

This trial will examine whether sending electronic reminders to obstetric care providers (nudge) can improve postpartum counseling and follow-up with preventative care providers for women with HDP.

Eligible Conditions

Pre-Eclampsia, Severe
Pre-eclampsia
Prophylaxis of Preeclampsia
Hypertension

REMIND Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months postpartum

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months postpartum

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of patients with documented counseling on transitions of care

Secondary outcome measures

Number of patients with documented counseling on cardiovascular disease (CVD) risk at the postpartum visit

Number of patients with preventative care follow-up

Number of postpartum visit notes using example text

+1 more

REMIND Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: NudgeExperimental Treatment1 Intervention

Obstetric care providers will receive electronic prompts (nudge) for participants in this arm

Group II: Usual careActive Control1 Intervention

Usual postpartum follow-up with visit at 4-12 weeks postpartum

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nudge

2022

N/A

~8850

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,881,987 Total Patients Enrolled

Jourdan E Triebwasser, MDPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants still being welcomed into this experiment?

"Clinicaltrials.gov reveals that, despite being posted on February 8th 2021 and last edited on November 21st 2022, this trial is not actively recruiting patients at present. However, there are 890 other medical trials in search of volunteers currently."

Answered by AI

Recent research and studies

Journal of General Internal MedicineJournal

Utilization of Primary and Obstetric Care After Medically Complicated Pregnancies: An Analysis of Medical Claims Data

Bennett, Wendy L., Hsien-Yen Chang, David M. Levine, Lin Wang, Donna Neale, Erika F. Werner, and Jeanne M. Clark. 2014. “Utilization of Primary and Obstetric Care After Medically Complicated Pregnancies: An Analysis of Medical Claims Data”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-013-2744-2.

CirculationJournal

Pregnancy Complications and Cardiovascular Disease Death

Cirillo, Piera M., and Barbara A. Cohn. 2015. “Pregnancy Complications and Cardiovascular Disease Death”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.113.003901.

The Journal of Maternal-Fetal & Neonatal MedicineJournal

Preeclampsia Outcomes at Delivery and Race

Gyamfi-Bannerman, Cynthia, Ambika Pandita, Eliza C. Miller, Amelia K. Boehme, Jason D. Wright, Zainab Siddiq, Mary E. D’Alton, and Alexander M. Friedman. 2019. “Preeclampsia Outcomes at Delivery and Race”. The Journal of Maternal-fetal & Neonatal Medicine. Informa UK Limited. doi:10.1080/14767058.2019.1581522.

Journal of the American Heart AssociationJournal